RÉSUMÉ
DEAD box helicase 41 (DDX41) mutations are the most prevalent predisposition to familial myelodysplastic syndrome (MDS). However, the precise roles of these variants in the pathogenesis of MDS have yet to be elucidated. Here, we discovered a novel mechanism by which DDX41 contributes to R-loop-induced DNA damage responses (DDR) in cooperation with the m6A-METTL complex (MAC) and YTHDC1 using DDX41 knockout (KO) and DDX41 knock-in (KI, R525H, Y259C) cell lines as well as primary samples from MDS patients. Compared to wild type (WT), DDX41 KO and KI led to increased levels of m6A RNA methylated R-loop. Interestingly, we found that DDX41 regulates m6A/R-loop levels by interacting with MAC components. Further, DDX41 promoted the recruitment of YTHDC1 to R-loops by promoting the binding between METTL3 and YTHDC1, which was dysregulated in DDX41-deficient cells, contributing to genomic instability. Collectively, we demonstrated that DDX41 plays a key role in the physiological control of R-loops in cooperation with MAC and YTHDC1. These findings provide novel insights into how defects in DDX41 influence MDS pathogenesis and suggest potential therapeutic targets for the treatment of MDS.
Sujet(s)
DEAD-box RNA helicases , Methyltransferases , Mutation , Syndromes myélodysplasiques , Facteurs d'épissage des ARN , Humains , DEAD-box RNA helicases/génétique , DEAD-box RNA helicases/métabolisme , Syndromes myélodysplasiques/génétique , Syndromes myélodysplasiques/anatomopathologie , Syndromes myélodysplasiques/métabolisme , Facteurs d'épissage des ARN/génétique , Facteurs d'épissage des ARN/métabolisme , Methyltransferases/génétique , Methyltransferases/métabolisme , Structures en boucle R , Altération de l'ADN , Liaison aux protéines , Protéines de tissu nerveuxRÉSUMÉ
Replication protein A (RPA), a eukaryotic single-stranded DNA (ssDNA) binding protein, dynamically interacts with ssDNA in different binding modes and plays essential roles in DNA metabolism such as replication, repair, and recombination. RPA accumulation on ssDNA due to replication stress triggers the DNA damage response (DDR) by activating the ataxia telangiectasia and RAD3-related (ATR) kinase, which phosphorylates itself and downstream DDR factors, including RPA. We recently reported that the N-methyl-D-aspartate receptor synaptonuclear signaling and neuronal migration factor (NSMF), a neuronal protein associated with Kallmann syndrome, promotes RPA32 phosphorylation via ATR upon replication stress. However, how NSMF enhances ATR-mediated RPA32 phosphorylation remains elusive. Here, we demonstrate that NSMF colocalizes and physically interacts with RPA at DNA damage sites in vivo and in vitro. Using purified RPA and NSMF in biochemical and single-molecule assays, we find that NSMF selectively displaces RPA in the more weakly bound 8- and 20-nucleotide binding modes from ssDNA, allowing the retention of more stable RPA molecules in the 30-nt binding mode. The 30-nt binding mode of RPA enhances RPA32 phosphorylation by ATR, and phosphorylated RPA becomes stabilized on ssDNA. Our findings provide new mechanistic insight into how NSMF facilitates the role of RPA in the ATR pathway.
Sujet(s)
Protein-Serine-Threonine Kinases , Protéine A de réplication , Protéines mutées dans l'ataxie-télangiectasie/métabolisme , Checkpoint kinase 1/métabolisme , Altération de l'ADN , Réplication de l'ADN , ADN simple brin , Protéines de liaison à l'ADN/génétique , Phosphorylation , Liaison aux protéines , Protein kinases/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protéine A de réplication/métabolisme , HumainsRÉSUMÉ
Genome instability is one of the leading causes of gastric cancers. However, the mutational landscape of driver genes in gastric cancer is poorly understood. Here, we investigate somatic mutations in 25 Korean gastric adenocarcinoma patients using whole-exome sequencing and show that PWWP2B is one of the most frequently mutated genes. PWWP2B mutation correlates with lower cancer patient survival. We find that PWWP2B has a role in DNA double-strand break repair. As a nuclear protein, PWWP2B moves to sites of DNA damage through its interaction with UHRF1. Depletion of PWWP2B enhances cellular sensitivity to ionizing radiation (IR) and impairs IR-induced foci formation of RAD51. PWWP2B interacts with MRE11 and participates in homologous recombination via promoting DNA end-resection. Taken together, our data show that PWWP2B facilitates the recruitment of DNA repair machinery to sites of DNA damage and promotes HR-mediated DNA double-strand break repair. Impaired PWWP2B function might thus cause genome instability and promote gastric cancer development.
Sujet(s)
Protéines chromosomiques nonhistones/métabolisme , Tumeurs de l'estomac , Protéines liant les séquences stimulatrices de type CCAAT/métabolisme , Cassures double-brin de l'ADN , Altération de l'ADN , Réparation de l'ADN , Instabilité du génome , Recombinaison homologue , Humains , Rad51 Recombinase/métabolisme , Réparation de l'ADN par recombinaison , Tumeurs de l'estomac/génétique , Ubiquitin-protein ligases/métabolismeRÉSUMÉ
Proper activation of DNA repair pathways in response to DNA replication stress is critical for maintaining genomic integrity. Due to the complex nature of the replication fork (RF), problems at the RF require multiple proteins, some of which remain unidentified, for resolution. In this study, we identified the N-methyl-D-aspartate receptor synaptonuclear signaling and neuronal migration factor (NSMF) as a key replication stress response factor that is important for ataxia telangiectasia and Rad3-related protein (ATR) activation. NSMF localizes rapidly to stalled RFs and acts as a scaffold to modulate replication protein A (RPA) complex formation with cell division cycle 5-like (CDC5L) and ATR/ATR-interacting protein (ATRIP). Depletion of NSMF compromised phosphorylation and ubiquitination of RPA2 and the ATR signaling cascade, resulting in genomic instability at RFs under DNA replication stress. Consistently, NSMF knockout mice exhibited increased genomic instability and hypersensitivity to genotoxic stress. NSMF deficiency in human and mouse cells also caused increased chromosomal instability. Collectively, these findings demonstrate that NSMF regulates the ATR pathway and the replication stress response network for genome maintenance and cell survival.
Sujet(s)
Protéines mutées dans l'ataxie-télangiectasie/métabolisme , Protéines du cycle cellulaire/métabolisme , Altération de l'ADN , Réparation de l'ADN , Protéines de liaison à l'ARN/métabolisme , Protéine A de réplication/métabolisme , Facteurs de transcription/physiologie , Animaux , Réplication de l'ADN , Cellules HEK293 , Cellules HeLa , Humains , Souris , Souris knockoutRÉSUMÉ
Reactive oxygen species (ROS) are important cellular second messengers involved in various aspects of cell signaling. ROS are elevated in multiple types of cancer cells, and this elevation is known to be involved in pathological processes of cancer. Although high levels of ROS exert cytotoxic effects on cancer cells, low levels of ROS stimulate cell proliferation and survival by inducing several prosurvival signaling pathways. In addition, ROS have been shown to induce epithelialmesenchymal transition (EMT), which is essential for the initiation of metastasis. However, the precise mechanism of ROSinduced EMT remains to be elucidated. In the present study, it was indicated that ROS induce EMT by activating Snail expression, which then represses Ecadherin expression in MCF7 cells. It was further indicated that distalless homeobox2 (Dlx2), one of the human Dlx gene family proteins involved in embryonic development, acts as an upstream regulator of ROSinduced Snail expression. It was also revealed that ROS treatment induces the glycolytic switch, a phenomenon whereby cancer cells primarily rely on glycolysis instead of mitochondrial oxidative phosphorylation for ATP production, even in the presence of oxygen. In addition, ROS inhibited oxidative phosphorylation and caused cytochrome c oxidase inhibition via the Dlx2/Snail cascade. These results suggest that ROS induce EMT, the glycolytic switch and mitochondrial repression by activating the Dlx2/Snail axis, thereby playing crucial roles in MCF7 cancer cell progression.
Sujet(s)
Tumeurs du sein/métabolisme , Transition épithélio-mésenchymateuse , Protéines à homéodomaine/métabolisme , Mitochondries/métabolisme , Espèces réactives de l'oxygène/métabolisme , Facteurs de transcription de la famille Snail/métabolisme , Facteurs de transcription/métabolisme , Femelle , Glycolyse , Humains , Cellules MCF-7 , Transduction du signalRÉSUMÉ
Rapidly growing malignant tumors frequently encounter hypoxia and nutrient (e.g., glucose) deprivation, which occurs because of insufficient blood supply. This results in necrotic cell death in the core region of solid tumors. Necrotic cells release their cellular cytoplasmic contents into the extracellular space, such as high mobility group box 1 (HMGB1), which is a nonhistone nuclear protein, but acts as a proinflammatory and tumor-promoting cytokine when released by necrotic cells. These released molecules recruit immune and inflammatory cells, which exert tumor-promoting activity by inducing angiogenesis, proliferation, and invasion. Development of a necrotic core in cancer patients is also associated with poor prognosis. Conventionally, necrosis has been thought of as an unregulated process, unlike programmed cell death processes like apoptosis and autophagy. Recently, necrosis has been recognized as a programmed cell death, encompassing processes such as oncosis, necroptosis, and others. Metabolic stress-induced necrosis and its regulatory mechanisms have been poorly investigated until recently. Snail and Dlx-2, EMT-inducing transcription factors, are responsible for metabolic stress-induced necrosis in tumors. Snail and Dlx-2 contribute to tumor progression by promoting necrosis and inducing EMT and oncogenic metabolism. Oncogenic metabolism has been shown to play a role(s) in initiating necrosis. Here, we discuss the molecular mechanisms underlying metabolic stress-induced programmed necrosis that promote tumor progression and aggressiveness.
Sujet(s)
Autophagie/physiologie , Mort cellulaire/physiologie , Nécrose/métabolisme , Tumeurs/anatomopathologie , Apoptose , Évolution de la maladie , HumainsRÉSUMÉ
Metastasis is a major obstacle to the efficient and successful treatment of cancer. Initiation of metastasis requires epithelial-mesenchymal transition (EMT) that is regulated by several transcription factors, including Snail and ZEB1/2. EMT is closely linked to the acquisition of cancer stem cell (CSC) properties and chemoresistance, which contribute to tumor malignancy. Tumor suppressor p53 inhibits EMT and metastasis by negatively regulating several EMT-inducing transcription factors and regulatory molecules; thus, its inhibition is crucial in EMT, invasion, metastasis, and stemness. Metabolic alterations are another hallmark of cancer. Most cancer cells are more dependent on glycolysis than on mitochondrial oxidative phosphorylation for their energy production, even in the presence of oxygen. Cancer cells enhance other oncogenic metabolic pathways, such as glutamine metabolism, pentose phosphate pathway, and the synthesis of fatty acids and cholesterol. Metabolic reprogramming in cancer is regulated by the activation of oncogenes or loss of tumor suppressors that contribute to tumor progression. Oncogenic metabolism has been recently linked closely with the induction of EMT or CSC phenotypes by the induction of several metabolic enzyme genes. In addition, several transcription factors and molecules involved in EMT or CSCs, including Snail, Dlx-2, HIF-1α, STAT3, TGF-ß, Wnt, and Akt, regulate oncogenic metabolism. Moreover, p53 induces metabolic change by directly regulating several metabolic enzymes. The collective data indicate the importance of oncogenic metabolism in the regulation of EMT, cell invasion and metastasis, and adoption of the CSC phenotype, which all contribute to malignant transformation and tumor development. In this review, we highlight the oncogenic metabolism as a key regulator of EMT and CSC, which is related with tumor progression involving metastasis and chemoresistance. Targeting oncometabolism might be a promising strategy for the development of effective anticancer therapy.
Sujet(s)
Transition épithélio-mésenchymateuse , Protéines tumorales/métabolisme , Tumeurs/métabolisme , Cellules souches tumorales/métabolisme , Facteurs de transcription/métabolisme , Animaux , Humains , Métastase tumorale , Tumeurs/anatomopathologie , Cellules souches tumorales/anatomopathologieRÉSUMÉ
Radiation therapy is one of the major tools of cancer treatment, and is widely used for a variety of malignant tumours. Radiotherapy causes DNA damage directly by ionization or indirectly via the generation of reactive oxygen species (ROS), thereby destroying cancer cells. However, ionizing radiation (IR) paradoxically promotes metastasis and invasion of cancer cells by inducing the epithelial-mesenchymal transition (EMT). Metastasis is a major obstacle to successful cancer therapy, and is closely linked to the rates of morbidity and mortality of many cancers. ROS have been shown to play important roles in mediating the biological effects of IR. ROS have been implicated in IR-induced EMT, via activation of several EMT transcription factors-including Snail, HIF-1, ZEB1, and STAT3-that are activated by signalling pathways, including those of TGF-ß, Wnt, Hedgehog, Notch, G-CSF, EGFR/PI3K/Akt, and MAPK. Cancer cells that undergo EMT have been shown to acquire stemness and undergo metabolic changes, although these points are debated. IR is known to induce cancer stem cell (CSC) properties, including dedifferentiation and self-renewal, and to promote oncogenic metabolism by activating these EMT-inducing pathways. Much accumulated evidence has shown that metabolic alterations in cancer cells are closely associated with the EMT and CSC phenotypes; specifically, the IR-induced oncogenic metabolism seems to be required for acquisition of the EMT and CSC phenotypes. IR can also elicit various changes in the tumour microenvironment (TME) that may affect invasion and metastasis. EMT, CSC, and oncogenic metabolism are involved in radioresistance; targeting them may improve the efficacy of radiotherapy, preventing tumour recurrence and metastasis. This study focuses on the molecular mechanisms of IR-induced EMT, CSCs, oncogenic metabolism, and alterations in the TME. We discuss how IR-induced EMT/CSC/oncogenic metabolism may promote resistance to radiotherapy; we also review efforts to develop therapeutic approaches to eliminate these IR-induced adverse effects.
Sujet(s)
Transition épithélio-mésenchymateuse , Cellules souches tumorales/effets des radiations , Radiotolérance , Dédifférenciation cellulaire , Humains , Métastase tumorale , Tumeurs , Cellules souches tumorales/métabolisme , Cellules souches tumorales/anatomopathologie , Phénotype , Espèces réactives de l'oxygène/métabolisme , Transduction du signalRÉSUMÉ
Most cancer cells depend on enhanced glucose and glutamine (Gln) metabolism for growth and survival. Oncogenic metabolism provides biosynthetic precursors for nucleotides, lipids, and amino acids; however, its specific roles in tumor progression are largely unknown. We previously showed that distal-less homeobox-2 (Dlx-2), a homeodomain transcription factor involved in embryonic and tumor development, induces glycolytic switch and epithelial-mesenchymal transition (EMT) by inducing Snail expression. Here we show that Dlx-2 also induces the expression of the crucial Gln metabolism enzyme glutaminase (GLS1), which converts Gln to glutamate. TGF-ß and Wnt induced GLS1 expression in a Dlx-2-dependent manner. GLS1 shRNA (shGLS1) suppressed in vivo tumor metastasis and growth. Inhibition of Gln metabolism by shGLS1, Gln deprivation, and Gln metabolism inhibitors (DON, 968 and BPTES) prevented Dlx-2-, TGF-ß-, Wnt-, and Snail-induced EMT and glycolytic switch. Finally, shDlx-2 and Gln metabolism inhibition decreased Snail mRNA levels through p53-dependent upregulation of Snail-targeting microRNAs. These results demonstrate that the Dlx-2/GLS1/Gln metabolism axis is an important regulator of TGF-ß/Wnt-induced, Snail-dependent EMT, metastasis, and glycolytic switch.
Sujet(s)
Transition épithélio-mésenchymateuse , Glutaminase/métabolisme , Glutamine/métabolisme , Glycolyse/physiologie , Protéines à homéodomaine/métabolisme , Tumeurs/anatomopathologie , Facteurs de transcription/métabolisme , Adénosine triphosphate/métabolisme , Apoptose , Technique de Western , Prolifération cellulaire , Immunoprécipitation de la chromatine , Technique d'immunofluorescence , Glutaminase/antagonistes et inhibiteurs , Glutaminase/génétique , Cellules HeLa , Cellules HepG2 , Protéines à homéodomaine/antagonistes et inhibiteurs , Protéines à homéodomaine/génétique , Humains , Cellules MCF-7 , Tumeurs/génétique , Tumeurs/métabolisme , ARN messager/génétique , Réaction de polymérisation en chaine en temps réel , RT-PCR , Transduction du signal , Facteurs de transcription de la famille Snail/antagonistes et inhibiteurs , Facteurs de transcription de la famille Snail/génétique , Facteurs de transcription de la famille Snail/métabolisme , Facteurs de transcription/antagonistes et inhibiteurs , Facteurs de transcription/génétique , Facteur de croissance transformant bêta/antagonistes et inhibiteurs , Facteur de croissance transformant bêta/génétique , Facteur de croissance transformant bêta/métabolisme , Cellules cancéreuses en cultureRÉSUMÉ
Epithelial-mesenchymal transition (EMT) and oncogenic metabolism (including glycolytic switch) are important for tumor development and progression. Here, we show that Dlx-2, one of distal-less (Dlx) homeobox genes, induces EMT and glycolytic switch by activation of Snail. In addition, it was induced by TGF-ß and Wnt and regulates TGF-ß- and Wnt-induced EMT and glycolytic switch by activating Snail. We also found that TGF-ß/Wnt suppressed cytochrome c oxidase (COX), the terminal enzyme of the mitochondrial respiratory chain, in a Dlx-2/Snail-dependent manner. TGF-ß/Wnt appeared to downregulate the expression of various COX subunits including COXVIc, COXVIIa and COXVIIc; among these COX subunits, COXVIc was a common target of TGF-ß, Wnt, Dlx-2 and Snail, indicating that COXVIc downregulation plays an important role(s) in TGF-ß/Wnt-induced COX inhibition. Taken together, our results showed that Dlx-2 is involved in TGF-ß- and Wnt-induced EMT, glycolytic switch, and mitochondrial repression by Snail activation.
Sujet(s)
Tumeurs du sein/anatomopathologie , Transition épithélio-mésenchymateuse , Glycolyse , Protéines à homéodomaine/génétique , Protéines à homéodomaine/métabolisme , Mitochondries/physiologie , Facteurs de transcription/génétique , Facteurs de transcription/métabolisme , Animaux , Tumeurs du sein/génétique , Tumeurs du sein/métabolisme , Lignée cellulaire tumorale , Chiens , Femelle , Cellules HCT116 , Humains , Cellules MCF-7 , Cellules rénales canines Madin-Darby , Facteurs de transcription de la famille Snail , Facteur de croissance transformant bêta/métabolisme , Voie de signalisation WntRÉSUMÉ
Necrosis is commonly found in the core region of solid tumours due to metabolic stress such as hypoxia and glucose deprivation (GD) resulting from insufficient vascularization. Necrosis promotes tumour growth and development by releasing the tumour-promoting cytokine high mobility group box 1 (HMGB1); however, the molecular mechanism underlying necrotic cell death remains largely unknown. In this study, we show that early growth response 1 (Egr-1) is induced in a reactive oxygen species (ROS)-dependent manner by GD in several cell lines such as A549, MDA-MB-231 and HepG2 cells that exhibit necrosis upon GD. We found that Egr-1 short hairpin RNA (shRNA) prevented GD-induced necrosis and HMGB1 release. Necrosis-inhibiting activity of Egr-1 shRNA was also seen in multicellular tumour spheroids (MTSs), an in vitro tumour model system. In contrast, Egr-1 overexpression appeared to make tumour cells more susceptible to GD-induced necrosis. Finally, Egr-1 shRNA suppressed the growth of MTSs. These findings demonstrate that Egr-1 is implicated in GD-induced necrosis and tumour progression.
Sujet(s)
Facteur de transcription EGR-1/génétique , Protéine HMGB1/métabolisme , Nécrose/génétique , Facteur de transcription EGR-1/métabolisme , Analyse de profil d'expression de gènes , Glucose/déficit , Cellules HepG2 , Humains , Cellules MCF-7 , Plasmides , Petit ARN interférent/génétique , Espèces réactives de l'oxygène/métabolisme , Sphéroïdes de cellules , 12-Myristate-13-acétate de phorbol/pharmacologie , TransfectionRÉSUMÉ
Wnt signaling plays a critical role in embryonic development, and its deregulation is closely linked to the occurrence of a number of malignant tumors, including breast and colon cancer. The pathway also induces Snail-dependent epithelial-to-mesenchymal transition (EMT), which is responsible for tumor invasion and metastasis. In this study, we show that Wnt suppresses mitochondrial respiration and cytochrome C oxidase (COX) activity by inhibiting the expression of 3 COX subunits, namely, COXVIc, COXVIIa, and COXVIIc. We found that Wnt induced a glycolytic switch via increased glucose consumption and lactate production, with induction of pyruvate carboxylase (PC), a key enzyme of anaplerosis. In addition, Wnt-induced mitochondrial repression and glycolytic switching occurred through the canonical ß-catenin/T-cell factor 4/Snail pathway. Short hairpin RNA-mediated knockdown of E-cadherin, a regulator of EMT, repressed mitochondrial respiration and induced a glycolytic switch via Snail activation, indicating that EMT may contribute to Wnt/Snail regulation of mitochondrial respiration and glucose metabolism. Together, our findings provide a new function for Wnt/Snail signaling in the regulation of mitochondrial respiration (via COX gene expression) and glucose metabolism (via PC gene expression) in tumor growth and progression.
Sujet(s)
Tumeurs du sein/métabolisme , Complexe IV de la chaîne respiratoire/métabolisme , Glucose/métabolisme , Facteurs de transcription/métabolisme , Protéines de type Wingless/métabolisme , Lignée cellulaire tumorale , Transition épithélio-mésenchymateuse , Femelle , Humains , Petit ARN interférent/pharmacologie , Transduction du signal , Facteurs de transcription de la famille Snail , Protéine-2 de type facteur-7 de transcription , Transfection , bêta-Caténine/métabolismeRÉSUMÉ
BACKGROUND: In contrast to tumor-suppressive apoptosis and autophagic cell death, necrosis promotes tumor progression by releasing the pro-inflammatory and tumor-promoting cytokine high mobility group box 1 (HMGB1), and its presence in tumor patients is associated with poor prognosis. Thus, necrosis has important clinical implications in tumor development; however, its molecular mechanism remains poorly understood. RESULTS: In the present study, we show that Distal-less 2 (Dlx-2), a homeobox gene of the Dlx family that is involved in embryonic development, is induced in cancer cell lines dependently of reactive oxygen species (ROS) in response to glucose deprivation (GD), one of the metabolic stresses occurring in solid tumors. Increased Dlx-2 expression was also detected in the inner regions, which experience metabolic stress, of human tumors and of a multicellular tumor spheroid, an in vitro model of solid tumors. Dlx-2 short hairpin RNA (shRNA) inhibited metabolic stress-induced increase in propidium iodide-positive cell population and HMGB1 and lactate dehydrogenase (LDH) release, indicating the important role(s) of Dlx-2 in metabolic stress-induced necrosis. Dlx-2 shRNA appeared to exert its anti-necrotic effects by preventing metabolic stress-induced increases in mitochondrial ROS, which are responsible for triggering necrosis. CONCLUSIONS: These results suggest that Dlx-2 may be involved in tumor progression via the regulation of metabolic stress-induced necrosis.
Sujet(s)
Antigènes de surface/métabolisme , Tumeurs/métabolisme , Stress physiologique , Antigènes de surface/génétique , Apoptose , Tumeurs du sein/métabolisme , Tumeurs du sein/anatomopathologie , Agrégation cellulaire , Lignée cellulaire tumorale , Tumeurs du côlon/métabolisme , Tumeurs du côlon/anatomopathologie , Femelle , Analyse de profil d'expression de gènes , Techniques de knock-down de gènes , Glucose/déficit , Humains , Potentiel de membrane mitochondriale , Mitochondries/métabolisme , Membranes mitochondriales/métabolisme , Nécrose , Tumeurs/anatomopathologie , Séquençage par oligonucléotides en batterie , Tumeurs de l'ovaire/métabolisme , Tumeurs de l'ovaire/anatomopathologie , Perméabilité , Interférence par ARN , Espèces réactives de l'oxygène/métabolisme , 12-Myristate-13-acétate de phorbol/pharmacologieRÉSUMÉ
BACKGROUND: Necrosis, a type of cell death accompanied by the rupture of the plasma membrane, promotes tumor progression and aggressiveness by releasing the pro-inflammatory and angiogenic cytokine high mobility group box 1. It is commonly found in the core region of solid tumors due to hypoxia and glucose depletion (GD) resulting from insufficient vascularization. Thus, metabolic stress-induced necrosis has important clinical implications for tumor development; however, its regulatory mechanisms have been poorly investigated. METHODOLOGY/PRINCIPAL FINDINGS: Here, we show that the transcription factor Snail, a key regulator of epithelial-mesenchymal transition, is induced in a reactive oxygen species (ROS)-dependent manner in both two-dimensional culture of cancer cells, including A549, HepG2, and MDA-MB-231, in response to GD and the inner regions of a multicellular tumor spheroid system, an in vitro model of solid tumors and of human tumors. Snail short hairpin (sh) RNA inhibited metabolic stress-induced necrosis in two-dimensional cell culture and in multicellular tumor spheroid system. Snail shRNA-mediated necrosis inhibition appeared to be linked to its ability to suppress metabolic stress-induced mitochondrial ROS production, loss of mitochondrial membrane potential, and mitochondrial permeability transition, which are the primary events that trigger necrosis. CONCLUSIONS/SIGNIFICANCE: Taken together, our findings demonstrate that Snail is implicated in metabolic stress-induced necrosis, providing a new function for Snail in tumor progression.
Sujet(s)
Nécrose/métabolisme , Nécrose/anatomopathologie , Stress physiologique , Facteurs de transcription/métabolisme , Hypoxie cellulaire , Glucose/déficit , Humains , Immunohistochimie , Potentiel de membrane mitochondriale , Mitochondries/métabolisme , Mitochondries/ultrastructure , Protéines de transport de la membrane mitochondriale/métabolisme , Pore de transition de perméabilité mitochondriale , Petit ARN interférent/métabolisme , Espèces réactives de l'oxygène/métabolisme , Facteurs de transcription de la famille Snail , Sphéroïdes de cellules/métabolisme , Sphéroïdes de cellules/anatomopathologie , Cellules cancéreuses en cultureRÉSUMÉ
Cancer cells frequently fail to respond to chemotherapy due to acquisition of chemoresistance. Tumour cells are prone to die by necrosis when they are metabolically stressed by hypoxic and glucose depletion (OGD) due to insufficient vascularization, a common feature of solid tumours. Tumour necrosis indicates poor prognosis and emergence of drug resistance in cancer patients; however, its molecular mechanism remains unclear. In this study, we used multicellular tumour spheroids (MTS) as an in vitro tumour model to investigate the molecular mechanisms underlying necrosis-linked drug resistance. MCF-7 cells formed tight and spherical shape of spheroids and started to form the necrotic core at 8 days of culture. We found that docetaxel (DOC)-induced apoptosis was gradually reduced during MCF-7 spheroid culture compared to that in monolayers and that more prominent resistance to DOC was observed when spheroids containing the necrotic core were treated. ERK1/2 and Akt appeared to be activated in MCF-7 spheroids with necrotic core, but not in 2D culture cells and in spheroids without necrotic core. DOC resistance in spheroids was reversed by inhibition of ERK1/2, but not of Akt, suggesting an important role for ERK1/2 in the DOC resistance in MCF-7 spheroids. These results provide new insight into the possible relation between necrosis-linked ERK1/2 activation and acquisition of multicellular resistance.
Sujet(s)
Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinase 1/métabolisme , Mitogen-Activated Protein Kinase 3/métabolisme , Taxoïdes/pharmacologie , Antinéoplasiques/pharmacologie , Lignée cellulaire tumorale , Docetaxel , Résistance aux médicaments antinéoplasiques , Humains , Protéines proto-oncogènes c-akt/métabolisme , Sphéroïdes de cellulesRÉSUMÉ
Cancer cells in the inner region of avascularized solid tumours experience metabolical stress by hypoxic and glucose depletion (OGD) and are prone to die by necrosis to form a necrotic core, a common feature of solid tumours. Unlike in apoptosis, where the cellular contents remain packed in the apoptotic bodies that are removed by macrophages, necrosis is characterized by cell membrane rupture, and the release of many cellular proteins including tumour promoting cytokine high mobility group box 1 (HMGB1) into the extra-cellular space. Although ROS produced by metabolic stress are known to cause membrane damage leading to the plasma membrane rupture, its molecular mechanism remains unclear. In this study, we show that some cellular proteins including pro-apoptotic molecules p53, caspase-3, and caspase-9 and a pro-autophagic molecule beclin 1 are not released into the extracellular space but rather aggregated in the cytosol during GD-induced necrosis and that the protein aggregation occurs in a ROS-dependent manner. We also found that Snail, the transcription factor that is induced by GD, was not translocated to the nucleus and aggregated in the cytosol. In addition, Snail interference appeared to block metabolic stress-induced protein aggregation, indicating a critical role(s) of Snail in the protein aggregation. These results demonstrate that in metabolically stressed cancer cells, ROS induce a specific set of cellular proteins to form insoluble aggregates that are highly toxic to cells and trigger the necrosis-associated membrane rupture and HMGB1 release to promote tumour progression.
Sujet(s)
Nécrose/étiologie , Protéines/métabolisme , Espèces réactives de l'oxygène/pharmacologie , Stress physiologique/physiologie , Réponse aux protéines mal repliées/physiologie , Précipitation chimique , Cytosol/métabolisme , Protéine HMGB1/métabolisme , Protéine HMGB1/physiologie , Cellules HepG2 , Humains , Nécrose/métabolisme , Tumeurs/métabolisme , Tumeurs/anatomopathologie , Protéines/effets des médicaments et des substances chimiques , Facteurs de transcription de la famille Snail , Stress physiologique/effets des médicaments et des substances chimiques , Facteurs de transcription/métabolisme , Facteurs de transcription/physiologie , Cellules cancéreuses en culture , Protéine p53 suppresseur de tumeur/métabolisme , Réponse aux protéines mal repliées/effets des médicaments et des substances chimiquesRÉSUMÉ
CuZnSOD and MnSOD have been shown to exert tumour suppressive activities; however, their exact molecular mechanism is still unclear. We investigated the molecular mechanism underlying the tumour suppressive activities of CuZnSOD and MnSOD using multicellular tumour spheroid (MTS), an in vitro tumour model. Overexpression of CuZnSOD and MnSOD significantly suppressed the growth of A549 and MCF-7 MTS, supporting a critical role(s) of reactive oxygen species (ROS) in tumour growth. In solid tumours, ROS is produced by metabolic stress due to insufficient oxygen and glucose supply and induces necrosis that is known to promote tumour progression by releasing the proinflammatory cytokine HMGB1. We observed that CuZnSOD and MnSOD overexpression prevents metabolic stress-induced necrosis and HMGB1 release by inhibiting mitochondrial ROS and intracellular O2- production in response to glucose depletion in two dimensional cell culture. CuZnSOD and MnSOD overexpression also significantly repressed the occurrence of necrosis that was observed during MTS culture. In human tumour tissues including lung pulmonary adenocarcinoma, CuZnSOD and MnSOD expression was detected in the para-necrotic region that was identified by the expression of a hypoxic marker carbonic anhydrase (CA) IX. These results suggest that CuZnSOD and MnSOD may suppress tumour growth through inhibiting metabolic stress-induced necrosis and HMGB1 release via inhibiting metabolic stress-induced mitochondrial ROS production.